BLCO

Bausch + Lomb Corporation is a leading global eye health company developing, manufacturing, and marketing a comprehensive range of eye care products including contact lenses, lens care solutions, pharmaceuticals, intraocular lenses, and surgical equipment. The company's portfolio includes leading brands such as Biotrue and Boston contact lens care products, Ultra and Infuse daily and monthly contact lenses, and surgical products for cataract and refractive procedures. Bausch + Lomb was part of Bausch Health Companies (formerly Valeant) and was partially spun off through an IPO in 2022, with Bausch Health retaining majority ownership. The company has a heritage dating to 1853 and global operations serving eye care professionals and consumers in more than 100 countries. Headquartered in Vaughan, Ontario, Canada, Bausch + Lomb competes with companies including Alcon, Johnson & Johnson Vision, and CooperVision. The company faces competitive pressures, pricing challenges, and the need for continuous innovation. Bausch + Lomb benefits from strong brand recognition, diversified product portfolio, and growing markets in Asia and other regions. The company continues to invest in research and development and commercial execution.